KPTI

Karyopharm management to meet with JMP Securities

moreView todays social media effects on KPTIView the latest stocks trending across Twitter. Click to view dashboardSee who Karyopharm is hiring next, click here to view […]

Karyopharm Therapeutics Reports First Quarter Financial Results for 2014

[GlobeNewswire] – NATICK, Mass. — Karyopharm Therapeutics Inc. , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets … moreView todays social media effects on KPTIView the latest stocks trending across Twitter. Click to view dashboardSee who Karyopharm is hiring next, click here to view […]

Karyopharm to Present at Upcoming Healthcare Conferences

[GlobeNewswire] – NATICK, Mass. — Karyopharm Therapeutics Inc. , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets … moreView todays social media effects on KPTIView the latest stocks trending across Twitter. Click to view dashboardSee who Karyopharm is hiring next, click here to view […]

9:05 am Karyopharm Therapeutics announces initiation of an investigator sponsored Phase 1 dose escalation study of its lead drug candidate Selinexor (KPT-330) in Singapore

moreView todays social media effects on KPTIView the latest stocks trending across Twitter. Click to view dashboardSee who Karyopharm is hiring next, click here to view […]

9:05 am Karyopharm Therapeutics announces initiation of an investigator sponsored Phase 1 dose escalation study of its lead drug candidate Selinexor (KPT-330) in Singapore

moreView todays social media effects on KPTIView the latest stocks trending across Twitter. Click to view dashboardSee who Karyopharm is hiring next, click here to view […]

Karyopharm Therapeutics Announces Initiation of an Investigator Sponsored Phase 1 Dose Escalation Study of Its Lead Drug Candidate Selinexor (KPT-330) in Singapore

[GlobeNewswire] – NATICK, Mass. — Karyopharm Therapeutics Inc. , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets … moreView todays social media effects on KPTIView the latest stocks trending across Twitter. Click to view dashboardSee who Karyopharm is hiring next, click here to view […]

Karyopharm Therapeutics Announces Initiation of an Investigator Sponsored Phase 1 Dose Escalation Study of Its Lead Drug Candidate Selinexor (KPT-330) in Singapore

[GlobeNewswire] – NATICK, Mass. — Karyopharm Therapeutics Inc. , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets … moreView todays social media effects on KPTIView the latest stocks trending across Twitter. Click to view dashboardSee who Karyopharm is hiring next, click here to view […]